The pair of M3 pharyngeal motor neurons form inhibitory syn apses on pharyngeal muscles
pm4 and
pm5 (Albertson and Thompson, 1976). In an
avr-15 mutant, M3 IPSPs are absent and iontophoretically applied glutamate no longer has a hyper polarizing effect on the pharyngeal muscle action potential.
avr-15 also confers sensitivity to ivermectin, a widely used anthelmintic drug.
avr-15 encodes two alternatively spliced channel subunits, GluClalpha2A and GluClalpha2B, that belong to the glutamate-gated chloride channel subunit family first described by Cully et al. (1994). A and B are essentially identical except that GluCla2A has an unusual addition of 202 amino acids at the beginning of the amino terminal domain. Promoter fusions of GluClalpha2A with GFP are expressed in pharyngeal corpus muscle
pm4 and the isthmus muscle
pm5, as expected, and in some extrapharyngeal neurons in the head. A full-length GluCla2AcDNA::GFP fusion appears to localize near the M3 synapse in
pm4. To look at the pharmacological binding proper ties of the AVR-15/GluClalpha2 channel subunits, we expressed GluClalpha2A in Xenopus oocytes. It formed a homomeric channel that responded to both glutamate and ivermectin. The glutamate response desensitizes rapidly with a maximal response around 5mM. The ivermectin response also desensitizes but to a much lesser extent and is irreversible. Thus AVR-15/GluClalpha2 medi ates inhibitory glutamatergic neurotransmission by M3 and ivermectin sensitivity in the pharynx.